NasdaqGS - Nasdaq Real Time Price USD

Prelude Therapeutics Incorporated (PRLD)

Compare
0.9133 +0.1133 (+14.16%)
As of 3:38:04 PM EST. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
3,000.0000
--
--
--
--
Operating Expense
146,262.0000
132,277.0000
123,540.0000
113,735.0000
58,763.0000
Operating Income
-143,262.0000
-132,277.0000
-123,540.0000
-113,735.0000
-58,763.0000
Other Income Expense
11,745.0000
10,445.0000
8,102.0000
2,041.0000
1,834.0000
Pretax Income
-131,517.0000
-121,832.0000
-115,438.0000
-111,694.0000
-56,929.0000
Net Income Common Stockholders
-131,517.0000
-121,832.0000
-115,438.0000
-111,694.0000
-56,929.0000
Diluted NI Available to Com Stockholders
-131,517.0000
-121,832.0000
-115,438.0000
-111,694.0000
-56,929.0000
Basic EPS
-1.77
-2.02
-2.44
-2.43
-4.56
Diluted EPS
-1.77
-2.02
-2.44
-2.43
-4.56
Basic Average Shares
74,236.6320
60,357.0520
47,371.5890
46,049.7630
12,478.4630
Diluted Average Shares
74,236.6320
60,357.0520
47,371.5890
46,049.7630
12,478.4630
Total Operating Income as Reported
-143,262.0000
-132,277.0000
-123,540.0000
-113,735.0000
-58,763.0000
Total Expenses
146,262.0000
132,277.0000
123,540.0000
113,735.0000
58,763.0000
Net Income from Continuing & Discontinued Operation
-131,517.0000
-121,832.0000
-115,438.0000
-111,694.0000
-56,929.0000
Normalized Income
-131,517.0000
-121,832.0000
-115,438.0000
-111,694.0000
-56,929.0000
EBIT
-143,262.0000
-132,277.0000
-123,540.0000
-113,735.0000
-58,763.0000
EBITDA
-141,648.0000
-131,108.0000
-122,216.0000
-112,820.0000
-58,221.0000
Reconciled Depreciation
1,614.0000
1,169.0000
1,324.0000
915.0000
542.0000
Net Income from Continuing Operation Net Minority Interest
-131,517.0000
-121,832.0000
-115,438.0000
-111,694.0000
-56,929.0000
Normalized EBITDA
-141,648.0000
-131,108.0000
-122,216.0000
-112,820.0000
-58,221.0000
12/31/2020 - 9/25/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PMVP PMV Pharmaceuticals, Inc.
1.5700
-0.63%
 
STTK Shattuck Labs, Inc.
1.0900
-4.39%
 
BOLD Boundless Bio, Inc.
2.5700
+4.47%
 
FHTX Foghorn Therapeutics Inc.
5.27
-0.57%
 
KYMR Kymera Therapeutics, Inc.
42.97
+1.98%
 
CGEM Cullinan Therapeutics, Inc.
11.71
-0.38%
 
INCY Incyte Corporation
70.21
+2.42%
 
DSGN Design Therapeutics, Inc.
6.26
+11.79%
 
ITOS iTeos Therapeutics, Inc.
7.72
+0.52%
 
ALLK Allakos Inc.
1.0550
+0.48%